|Bid||0.0000 x 3000|
|Ask||0.0000 x 1200|
|Day's range||3.3400 - 3.4200|
|52-week range||2.9200 - 17.9500|
|Beta (5Y monthly)||-0.01|
|PE ratio (TTM)||N/A|
|Earnings date||13 Oct 2021 - 18 Oct 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.50|
If you want to know who really controls Brainstorm Cell Therapeutics Inc. ( NASDAQ:BCLI ), then you'll have to look at...
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
A look at the shareholders of Brainstorm Cell Therapeutics Inc. ( NASDAQ:BCLI ) can tell us which group is most...